Results 31 to 40 of about 19,509 (202)

Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink.

Journal of Comparative Effectiveness Research, 2022
Aim: To compare blood pressure (BP) and safety outcomes in patients with hypertension initiating bisoprolol, versus other β-blockers, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, calcium channel blockers or diuretics ...
C. Foch, A. Allignol, T. Hohenberger, E. Boutmy, S. Schaefer, U. Hostalek   +5 more
semanticscholar   +1 more source

A growing evidence base for the fixed-dose combination of bisoprolol and amlodipine to manage hypertension

Current Medical Research and Opinion, 2022
Objectives Hypertension is a major cause of morbidity and mortality worldwide. Although current drug therapies can be effective, management of hypertension is closely linked to patient adherence to therapy.
Ulrike Hostalek-Gottwald, Z. Gaciong
semanticscholar   +1 more source

The possibilities of using beta-blocker bisoprolol in patients with stable angina with concomitant bronchial asthma.

Kardiologiia, 2022
Aim    To compare efficacy and safety of treatments with the calcium antagonist (CA) verapamil, the cardioselective β-blocker (BB) bisoprolol, and a combination therapy with bisoprolol and amlodipine in patients with stable angina (SA) with concurrent ...
N. Grigorieva, T. Ilushina, K. Kolosova
semanticscholar   +1 more source

To Evaluate the 'Real World' Clinical Performance of Bisoprolol in Post-Myocardial Infarction with Left Ventricular Dysfunction: Tenacity Study.

Journal of Association of Physicians of India, 2022
Beta-blockers are the cornerstone in management of heart failure and are well studied in Acute Coronary Syndromes (ACS). There is paucity of data of Bisoprolol in acute ICU setting in patients admitted with left ventricular systolic dysfunction (LVSD ...
K. Sharma, Hardik D. Desai, Neha Sharm, M. Laddha, K. Hansora, P. Vazirani   +5 more
semanticscholar   +1 more source

Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension

Frontiers in Cardiovascular Medicine, 2022
Purpose This study examined the effects of plasma renin activity (PRA), angiotensin II (Ang II) and aldosterone (PAC) concentrations as well as common polymorphisms in the β1-Adrenoceptor gene (ADRB1) and the G-protein α-Subunit (Gαs) protein gene the G ...
Weiwei Zeng, T. Chu, C. Ho, C. W. Lo, A. Chan, A. Kong, B. Tomlinson, S. Chan   +7 more
semanticscholar   +1 more source

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers

Journal of Cardiothoracic Surgery, 2023
Background Postoperative atrial fibrillation (POAF) after open-heart surgery is a non-negligible complication. We aimed to describe the efficacy of a transdermal patch of bisoprolol for managing POAF and flutter in thoracic surgical procedures.
Kenji Yamamoto, Senri Miwa, Tomoyuki Yamada, Shuji Setozaki, Mamoru Hamuro, Shunji Kurokawa, Sakae Enomoto   +6 more
doaj   +1 more source

The effect of rs776746 polymorphism in the CYP3A5 gene on heart rate when using bisoprolol in patients with acute coronary syndrome

Рациональная фармакотерапия в кардиологии, 2022
Aim. The aim of this work was to study the occurrence of the rs776746 allelic variant of the CYP3A5 gene and its effect on heart rate (HR) when using bisoprolol in patients hospitalized with acute coronary syndrome (ACS).Materials and methods.
V. A. Shumkov, K. A. Zagorodnikova, S. A. Boldueva, A. A. Murzina   +3 more
doaj   +1 more source

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

Cardiovascular Drugs and Therapy, 2021
Bisoprolol and nebivolol are highly selective β 1 -adrenoceptor antagonists, with clinical indications in many countries within the management of heart failure with reduced left ventricular ejection fraction (HFrEF), ischaemic heart disease (IHD), and ...
W. Alhabeeb, Sanaa Mrabeti, A. Abdelsalam   +2 more
semanticscholar   +1 more source

EFFICACY AND SAFETY OF IVABRADINE AND BISOPROLOL IN PATIENTS WITH ISCHEMIC HEART DISEASE: RESULTS OF COMPARATIVE RANDOMIZED OPEN STUDY

Рациональная фармакотерапия в кардиологии, 2016
Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic indices, exercise tolerance, endothelial function, quality of life (QL) and erectile function in patients with ischemic heart disease. Material and methods.
R. D. Kurbanov, A. O. Kan, F. M. Bekmetova, A. B. Shek   +3 more
doaj   +1 more source

The Role of Lisinopril and Bisoprolol to Prevent Anthracycline Induced Cardiotoxicity in Locally Advanced Breast Cancer Patients

Asian Pacific Journal of Cancer Prevention, 2021
Background: Anthracyclines are a class of chemotherapeutic agents that are used to treat many different cancers, including breast cancer. Although anthracyclines remain an effective and commonly used therapy, their use is limited by cardiotoxicity. Heart
Asdi Wihandono, Y. Azhar, Maman Abdurahman, Sjarief Hidayat   +3 more
semanticscholar   +1 more source